Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?

Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania. Pharmacoeconomics (2016) 0.75

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62

GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02

Epidemiology of drug-resistant malaria. Lancet Infect Dis (2002) 7.59

Artesunate combinations for treatment of malaria: meta-analysis. Lancet (2004) 7.54

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol (2009) 3.84

A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods (2010) 3.52

Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev (2009) 3.26

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One (2008) 2.78

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials (2007) 2.63

Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One (2009) 2.43

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin Infect Dis (2009) 2.42

Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Malar J (2010) 2.04

Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania. BMC Public Health (2008) 1.85

Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets. Malar J (2009) 1.78

Malaria and pregnancy: a global health perspective. Rev Obstet Gynecol (2009) 1.65

Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis (2013) 1.61

A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Malar J (2008) 1.43

Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Malar J (2011) 1.38

A systematic comparison of software dedicated to meta-analysis of causal studies. BMC Med Res Methodol (2007) 1.30

Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Malar J (2011) 1.22

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies. Trans R Soc Trop Med Hyg (2012) 1.22

Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. Trop Med Int Health (2008) 1.18

Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children. Malar J (2009) 1.12

Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment. Malar J (2012) 1.03

Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria. Antimicrob Agents Chemother (2011) 1.00

Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan. Ann Trop Med Parasitol (2010) 0.99

Potential of artemisinin-based combination therapies to block malaria transmission. J Infect Dis (2013) 0.92